bargain
add to cartAbstract
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural
CJC-1295 is a Long acting GHRH analog.hormone-releasing hormone (GHRH), also known as hormone-releasing factor (GRF or GHRF) or somatocrinin, is a 44-amino acid peptide hormone produced in the hypothalamus by the arcuate nucleus. GHRH stimulates hormone (GH) secretion from the pituitary. GHRH is released in a pulsatile manner, stimulating pulsatile release of GH respectively.
Specification
| Product name | CJC-1295 Acetate |
| CAS register number | 863288-34-0 |
| Molecular formula | C165H271N47O46 |
| Molecular weight | 3649.30 |
| Assay | 99% |
| Appearance | White powder |
| Single Impurity(HPLC) | 1.0%max |
| Amino Acid Composition | 10% of theoretical |
| Peptide Content(N%) | 80%(by %N) |
| Water Content(Karl Fischer) | 6.0% |
| Acetate Content(HPIC) | 15.0% |
| MS (ESI) | Consistent |
| Mass Balance | 95.0~105.0% |
Application
CJC1295 DAC has shown some amazing results as a hormone releasing hormone (GHRH) analog. Not only has CJC1295 shown the ability to increase hormone and secretion and its benefits, but it has been able to do so in very large amounts. Recent research studies have shown that CJC - 1295 stimulates GH and Secretion, and will keep a steady increase with no increase in prolactin, leading to intense fat loss, and increases protein synthesis.
CJC-1295 DAC is a long acting Hormone Releasing Hormone, which causes the anterior pituitary to release more hormone. The objective of the peptide was to treat visceral fat deposits in obese AIDS patients, as increased levels of exogenous are presumed to increase lipolysis (fat loss).
The clinical research was ultimately successful for most research subjects. Ghrelin, released from the gut, which circulates and acts as a hunger hormone, has synergistic activity in the body with GHRH and also suppresses somatostatin to make way for the GHRH pulse. An example of a GHRP (GH Releasing Peptide) is Hexarelin or GHRP2. CJC 1295 DAC is a exceptionally designed peptide and is known for being the finest of the secretogues.
The Result of Such Process Increases
Because CJC-1295 No DAC has been shown to boost GHRH1-29's half-life, scientific study based on animal test subjects has determined that the peptide's presence can play a vital role in boosting specific functional processes, especially those that relate to protein synthesis. Some of the conceived benefits that the peptide has been linked to include a more efficient means of breaking down adipose tissue, an increase in muscular and skeletal tissue growth, an increase in bone density, and a boosted immune system. It has also been theorized that the peptide can be responsible for improving deep sleep, since that is the period where most protein synthesis occurs.
Purely for Scientific Research
Despite the fact that there has been plenty of research on CJC-1295 No DAC in relation to how it functions and the benefits that can be derived from such functionality, it should be emphasized that the peptide is still just intended for scientific study at this point in time. Because of this, any findings or observations relating to CJC-1295 No DAC should exclusively be the product of study performed in a strictly contained environment such as a medical research facility or a laboratory.
Skype&Whatsapp:86 13690838732
Email: ycsales12@ycphar.com
